Icon

ANNOVIS BIO INC. DL-0001 Stock Analysis and Price Target COMMON STOCK | Biotechnology | F

N/A

Average User
Rating

N/A

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis

EUR 16.82

0.00 (0.00)%

EUR 0.14B

25.00

N/A

N/A

Icon

07X:F

ANNOVIS BIO INC. DL-0001 (EUR)
COMMON STOCK | F
EUR 16.82
0.00 0

N/A

Average User
Rating

N/A

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis

EUR 0.14B

N/A

EUR 16.82

ANNOVIS BIO INC. DL-0001 Stock Forecast

N/A

Based on the ANNOVIS BIO INC. DL-0001 stock forecasts from 0 analysts, the average analyst target price for ANNOVIS BIO INC. DL-0001 is not available over the next 12 months. ANNOVIS BIO INC. DL-0001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ANNOVIS BIO INC. DL-0001 is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, ANNOVIS BIO INC. DL-0001’s stock price was EUR 16.82. ANNOVIS BIO INC. DL-0001’s stock price has changed by +11.28% over the past week, +7.13% over the past month and 0% over the last year.

No recent analyst target price found for ANNOVIS BIO INC. DL-0001
No recent average analyst rating found for ANNOVIS BIO INC. DL-0001

Company Overview

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndr...Read More

N/A

N/A

3

N/A

EUR

Germany

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To ANNOVIS BIO INC. DL-0001 (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NOVA:F
Novo Nordisk A/S 0.00 (0.00%) EUR314.98B 42.68 3.51

ETFs Containing 07X

Symbol Name Weight Mer Price(Change) Market Cap
no data

Frequently Asked Questions About 07X:F Stock

Stock Target Advisor's fundamental analysis for ANNOVIS BIO INC. DL-0001's stock is Neutral.

Unfortunately we do not have enough data on 07X:F's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 07X:F's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on 07X:F's stock to indicate if its overvalued.

The last closing price of 07X:F's stock was EUR 16.82.

The most recent market capitalization for 07X:F is EUR 0.14B.

Unfortunately we do not have enough analyst data on 07X:F's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...